Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Fibroblast-specific IKK-β deficiency ameliorates angiotensin II–induced adverse cardiac remodeling in mice
Weiwei Lu, Zhaojie Meng, Rebecca Hernandez, Changcheng Zhou
Weiwei Lu, Zhaojie Meng, Rebecca Hernandez, Changcheng Zhou
View: Text | PDF
Research Article Cardiology

Fibroblast-specific IKK-β deficiency ameliorates angiotensin II–induced adverse cardiac remodeling in mice

  • Text
  • PDF
Abstract

Cardiac inflammation and fibrosis contribute significantly to hypertension-related adverse cardiac remodeling. IκB kinase β (IKK-β), a central coordinator of inflammation through activation of NF-κB, has been demonstrated as a key molecular link between inflammation and cardiovascular disease. However, the cell-specific contribution of IKK-β signaling toward adverse cardiac remodeling remains elusive. Cardiac fibroblasts are one of the most populous nonmyocyte cell types in the heart that play a key role in mediating cardiac fibrosis and remodeling. To investigate the function of fibroblast IKK-β, we generated inducible fibroblast-specific IKK-β–deficient mice. Here, we report an important role of IKK-β in the regulation of fibroblast functions and cardiac remodeling. Fibroblast-specific IKK-β–deficient male mice were protected from angiotensin II–induced cardiac hypertrophy, fibrosis, and macrophage infiltration. Ablation of fibroblast IKK-β inhibited angiotensin II–stimulated fibroblast proinflammatory and profibrogenic responses, leading to ameliorated cardiac remodeling and improved cardiac function in IKK-β–deficient mice. Findings from this study establish fibroblast IKK-β as a key factor regulating cardiac fibrosis and function in hypertension-related cardiac remodeling.

Authors

Weiwei Lu, Zhaojie Meng, Rebecca Hernandez, Changcheng Zhou

×

Figure 4

Ablation of IKK-β in fibroblasts ameliorates angiotensin II–induced cardiac dysfunction.

Options: View larger image (or click on image) Download as PowerPoint
Ablation of IKK-β in fibroblasts ameliorates angiotensin II–induced card...
Eight-week-old male IKKβfl/fl and IKKβΔFib mice were i.p. injected with 2 mg tamoxifen per day for 5 days. At the age of 10 weeks, those mice were infused with 1000 ng/kg/min of angiotensin II (Ang II) or vehicle control for 4 weeks. (A) Representative images of M-mode echocardiography of left ventricles (LVs). (B) Echocardiographic analysis of heart rate (HR), ejection fraction (EF), fractional shortening (FS), interventricular septum diameter at end diastole (IVSd), LV internal dimension at end-diastole (LVIDd), and LV posterior wall at end-diastole (LVPWd) (n = 8–12; 2-way ANOVA; *P < 0.05, **P < 0.01, ***P < 0.001). (C) Measurements of systolic, diastolic, and mean blood pressure (n = 7–8; 2-way ANOVA; ***P < 0.001).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts